NetPath: a public resource of curated signal transduction pathways
- Kumaran Kandasamy†1, 2,
- S Sujatha Mohan†1, 3,
- Rajesh Raju1, 4,
- Shivakumar Keerthikumar1,
- Ghantasala S Sameer Kumar1,
- Abhilash K Venugopal1,
- Deepthi Telikicherla1,
- J Daniel Navarro1,
- Suresh Mathivanan1,
- Christian Pecquet3,
- Sashi Kanth Gollapudi1,
- Sudhir Gopal Tattikota1,
- Shyam Mohan1,
- Hariprasad Padhukasahasram1,
- Yashwanth Subbannayya1,
- Renu Goel1,
- Harrys KC Jacob1, 2,
- Jun Zhong2,
- Raja Sekhar1,
- Vishalakshi Nanjappa1,
- Lavanya Balakrishnan1,
- Roopashree Subbaiah1,
- YL Ramachandra4,
- B Abdul Rahiman4,
- TS Keshava Prasad1,
- Jian-Xin Lin5,
- Jon CD Houtman6,
- Stephen Desiderio7,
- Jean-Christophe Renauld8,
- Stefan N Constantinescu8,
- Osamu Ohara9, 10,
- Toshio Hirano11, 12,
- Masato Kubo13, 14,
- Sujay Singh15,
- Purvesh Khatri16,
- Sorin Draghici16, 17,
- Gary D Bader18, 19,
- Chris Sander19,
- Warren J Leonard5 and
- Akhilesh Pandey2, 20Email author
© Kandasamy et al.; licensee BioMed Central Ltd. 2010
Received: 21 April 2009
Accepted: 12 January 2010
Published: 12 January 2010
We have developed NetPath as a resource of curated human signaling pathways. As an initial step, NetPath provides detailed maps of a number of immune signaling pathways, which include approximately 1,600 reactions annotated from the literature and more than 2,800 instances of transcriptionally regulated genes - all linked to over 5,500 published articles. We anticipate NetPath to become a consolidated resource for human signaling pathways that should enable systems biology approaches.
Complex biological processes such as proliferation, migration and apoptosis are generally regulated through responses of cells to stimuli in their environment. Signal transduction pathways often involve binding of extracellular ligands to receptors, which trigger a sequence of biochemical reactions inside the cell. Generally, proteins are the effector molecules, which function as part of larger protein complexes in signaling cascades. Cellular signaling events are generally studied systematically through individual experiments that are widely scattered in the biomedical literature. Assembling these individual experiments and putting them in the context of a signaling pathway is difficult, time-consuming and cannot be automated.
The availability of detailed signal transduction pathways that can easily be understood by humans as well as be processed by computers is of great value to biologists trying to understand the working of cells, tissues and organ systems . A systems-level understanding of any biological process requires, at the very least, a comprehensive map depicting the relationships among the various molecules involved . For instance, these maps could be used to construct a complete network of protein-protein interactions and transcriptional events, which would help in identifying novel transcriptional and other regulatory networks . These can be extended to predict how the interactions, if perturbed singly or in combination, could affect individual biological processes. Additionally, they could be used to identify possible unintended effects of a candidate therapeutic agent on any clusters in a pathway . We have developed a resource called NetPath that allows biomedical scientists to visualize, process and manipulate data pertaining to signaling pathways in humans.
Results and discussion
Development of NetPath as a resource for signal transduction pathways
Immune signaling pathway statistics
Molecular association events
Number of upregulated genes annotated
Number of downregulated genes annotated
Number of PubMed links
T cell receptor
B cell receptor
Signaling pathway annotation
To facilitate annotation of pathway data, we first developed a tool called 'PathBuilder' . PathBuilder is a signal transduction pathway annotation tool that allows annotation of pathway information, storage of data, easy retrieval and export into community standardized data structures such as BioPAX (Biological Pathways Exchange) , PSI-MI (Proteomics Standards Initiative - Molecular Interactions)  and SBML (Systems Biology Markup Language)  formats. PathBuilder facilitates the entry of information pertaining to protein interactions, enzyme-regulated reactions, intracellular translocation events and genes that are transcriptionally regulated.
Protein-protein interactions could be binary when two proteins directly interact with each other - 'direct interaction' - or when the proteins are present in a complex of proteins - 'complex interaction'. Both types of protein interactions are comprehensively collected from the literature. We provide PubMed identifiers, experiment type and host organism in which the interaction has been detected.
Enzyme-regulated reactions such as post-translational modifications (for example, phosphorylation, proteolytic cleavage, ubiquitination, prenylation or sulfation) are annotated as catalysis interactions. For each catalysis or modification event, the upstream enzyme, downstream targets and the site of the modification for a protein are annotated, if available. Proteins that translocate from one compartment (for example, the cytoplasm) to another (for example, the nucleus) are represented as transport events. For all reactions, a brief comment describing the reaction is also provided.
Display of pathway information
The homepage of any given pathway contains a brief description of the pathway, a summary of the reaction statistics and a list of the molecules involved in the pathway. Reactions in a pathway are provided under three distinct categories, including physical interactions, enzyme catalysis and transport. Furthermore, the pathway data are also provided in PSI-MI, BioPAX and SBML formats, which can also be visualized through other external network visualization software, such as Cytoscape .
Cataloging transcriptionally regulated genes
In addition to the above pathway annotations, information on genes that are transcriptionally regulated is provided in NetPath. This is important because addition of most extracellular growth factors or ligands leads to an alteration in the transcriptome of the cell. Often, some of the transcriptionally regulated genes are used as 'reporters' in biological experiments where the pathway is being studied. We have cataloged a number of genes that are up- or down-regulated by the particular ligand involved in each pathway. These up/down-regulated genes can be considered as 'signatures' for that particular pathway. We have incorporated both microarray and non-microarray (for example, Northern blot, quantitative RT-PCR, serial analysis of gene expression (SAGE), and so on) experiments for gene expression. In each case, the type of experiment (that is, microarray, non-microarray or both) used to obtain the data is indicated. Additionally, we have also annotated the transcription factors that are responsible for transcriptional regulation of the downstream genes where such information is available. Given the large number of transcriptionally regulated genes for each pathway, we have also developed a query system that permits users to search such genes using gene symbol or accession numbers. This feature will be valuable for shortlisting genes that are common to several pathways or specific to any given pathway.
At present the 10 annotated immune signaling pathways comprise 703 proteins and 1,572 reactions. The reactions can be grouped into 740 molecular association events, 727 enzyme catalysis events and 105 translocation events. Our pathways provide a list of 2,004 and 889 genes that are up- or down-regulated, respectively, at the level of mRNA expression. Including 10 cancer signaling pathways that are also available through Cancer Cell Map , NetPath now contains 1,682 proteins and 3,219 reactions, which can be grouped into 1,800 molecular association events, 1,218 enzyme catalysis events and 201 transport events. Table 1 shows the overall immune signaling pathway statistics as of 1 November 2009.
Comparison with other signaling databases
Comparison of salient features of NetPath with other popular curated signaling pathway resources
Query option for pathway molecules
Genes transcriptionally regulated by pathway included?
Pathways reviewed by experts?
File formats available for download
Textual description of reactions provided?
Other features or comments
BioPAX, PSI-MI, SBML, Excel, Tab-delimited
Focus on human receptor mediated signaling. Also contains separate molecule pages with brief summary of the biology of the individual molecules
No download option provided
BioCarta provides commercial links to antibody reagents
Science's STKE 
Contains species-specific and also cell-type-specific pathways
Contains disease specific pathways
BioPAX, SBML, PDF, SVG, Protégé, MySQL database dump
Also contains computationally inferred pathway reactions
XML, BioPAX, SVG, JPG
Apart from NCI-Nature curated pathways, it also contains many pathways imported from BioCarta/Reactome
Yes (in some cases)
Provides pathway information along with links to protein and commercial products available for that protein
GPML, GenMAPP, PDF, PNG, SVG
Any user can register and create a new pathway and also edit existing pathways
Reviewed by Curation Coordinator
SBML, SBGN, PNG
Allows community pathway curation and also provides links to Applied Biosystems genomic products
Interleukin-2 pathway as a prototype
One of the best studied immune signaling pathways is the interleukin (IL)-2 signaling pathway . IL-2 is a multifunctional cytokine with pleiotropic effects on several cells of the immune system [27, 28]. IL-2 was originally discovered as a T cell growth factor , but it was also found to have actions related to B cell proliferation , and the proliferation and cytolytic activity of natural killer cells . IL-2 also activates lymphokine activated killer cells . In contrast to its proliferative effects, IL-2 also has potent activity in a process known as activation-induced cell death . More recently, IL-2 was shown to promote tolerance through its effects on regulatory T cell development . IL-2 clinically has anti-cancer effects  as well as utility in supporting T cell numbers in HIV/AIDS .
There are three classes of IL-2 receptors, binding IL-2 with low, intermediate, or high-affinity . The low affinity receptor (IL-2Rα alone) is not functional; signaling by IL-2 involves either the high affinity hetero-trimeric receptor containing IL-2Rα, IL-2Rβ and the common cytokine receptor gamma chain (originally named IL-2Rγ and now generally denoted as γc) or the intermediate affinity heterodimeric receptor composed of IL-2Rβ and γc [37, 38]. Mutations in the IL2RG gene result in X-linked severe combined immunodeficiency disease . IL-2 stimulation induces the activation of the Janus family tyrosine kinases JAK1 and JAK3, which associate with IL-2Rβ and γc, respectively. These kinases in turn phosphorylate IL-2Rβ and induce tyrosine phosphorylation of STATs (signal transducers and activators of transcription) and various other downstream targets . The downstream signaling pathway also involves mitogen-activated protein kinase and phosphoinositide 3-kinase signaling modules , leading to both mitogenic and anti-apoptotic signals [40–42].
Integration of pathway information with other resources
The pathways developed by us have been integrated with the Human Protein Reference Database (HPRD) [43, 44]. The integration of pathways in HPRD helps identify each component of the pathway in the context of its detailed proteomic annotations . As part of our community participation with other databases/resources, we hope to establish connections with other pathway databases such as KEGG  and Reactome  in the future.
Availability of pathway data
A digital representation of pathways is essential to be able to manipulate the large amount of available information . The diversity among pathway databases is also reflected in differences in data models, data access methods and file formats. This leads to the incompatibility of data formats for the analysis of pathway data. To avoid this, data standards are adopted by many of the pathway databases [12, 46]. Data standards reduce the total number of translation operations needed to exchange data between multiple sources. To facilitate easy information retrieval from a wide variety of pathway resources, a broad effort in the biological pathways community called BioPAX was initiated. Since many less-detailed data types in a pathway database are difficult to represent in a very detailed format, BioPAX ontology uses hierarchical entity classes to present multiple levels of data resolution. All pathways in NetPath are available for download in BioPAX level 2, version 1.0. The PSI-MI format was developed to exchange molecular interaction data between databases containing protein-protein interactions. PSI-MI data representation facilitates data comparison, exchange and verification . The molecular interaction subset of NetPath pathways is also available in PSI-MI version 2.5. SBML was developed as a medium for representation and exchange of biochemical network models . NetPath provides all pathway data in SBML version 2.1 format. All data are made available under the Creative Commons license version 2.5 , which stipulates that the pathways may be freely used if adequate credit is given to the authors. Support for these data standards and free license enables the integration of knowledge from multiple sources in a coherent and reliable manner.
Enabling semantic web for NetPath
The semantic web envisions an internet where specific information can be obtained from the web automatically using computers. Because providing computers with the intuitiveness of humans is nearly impossible as of now, creation of meta-data - data about data - can help computers identify what is being sought less ambiguously. However, annotating more data does not automatically imply that the data can be made easily accessible by the user. For instance, although many resources permit direct querying of individual molecules in the respective databases, queries based on 'relationships' between different entries in the databases cannot be handled. One possible solution to enable searching by such 'concepts' is to incorporate semantic web features that explicitly describe the inter-relationship between entries in the databases.
The W3C has established SPARQL as the standard semantic query language. Pathway data in BioPAX uses the web ontology language (OWL) format, which is highly descriptive in nature and can be used to make pathways semantically 'queryable'. In this regard, we have implemented an application programming interface (API) for NetPath that accepts SPARQL over HTTP to query the BioPAX files describing NetPath pathways. The return results are provided in SPARQL Query Results XML format. Although biologists cannot be expected to write SPARQL queries, the ability to send SPARQL queries over HTTP allows bioinformaticians to write client applications that can retrieve NetPath resources taking advantage of the descriptive richness of SPARQL and BioPAX.
Analyzing impact factor for pathways
It is becoming clear that pathway information can be used in the context of genome-scale gene expression experiments. A novel approach has been recently reported to measure the biological impact of perturbation of pathways in genomewide gene expression experiments . This approach considers the topology of genes in a pathway in conjunction with classical statistics for microarray analysis. The impact factor is a statistical approach that can capture the magnitude of the expression changes of each gene, the position of the differentially expressed genes on the given pathways, the topology of the pathway that describes how these genes interact, and the type of signaling interactions between them. Our previous results using KEGG pathways were found to correlate with known biological events that were missed by other widely used classical analysis methods. However, this approach could not be applied to study immune responses because of the limited availability of data on such pathways in humans.
As a proof of principle, we selected publicly available mRNA expression datasets from Gene Expression Omnibus (GEO), a repository for gene expression data . Datasets that include expression analysis of immune cells under different experimental conditions were selected for this purpose.
One of the datasets used [GEO:GDS2214] (as described in ) was an experimental study of mRNA expression analysis of neutrophils isolated from blood of patients with sepsis-induced acute lung injury. The neutrophils were cultured with either lipopolysaccharide (LPS) or high mobility group box protein 1 (HMGB1), both of which are known to be mediators of the inflammatory response. Gene expression analysis was carried out using the Affymetrix GeneChip Human Genome U133 Array Set HG-U133A oligonucleotide gene chip. The authors found enhancement of nuclear translocation activity of NF-kappaB and phosphorylation of Akt and p38 mitogen-activated protein kinase upon stimulation of LPS or HMGB1. We carried out impact factor analysis using this dataset on all ten immune signaling pathways. The results corroborate with these findings since IL-1 and IL-6 pathway scores are highly affected while the rest of the NetPath pathways did not show significant scores.
Another dataset selected [GEO:GDS1407] (described in ) was a part of the gene expression study that screened a cohort of 102 healthy individuals to investigate the distribution of inflammatory responses to LPS in the normal population in circulating leukocytes. Expression profiling with Affymetrix U95AV2 oligonucleotide microarray identified differentially regulated genes between two phenotypic subgroups that have been described as high LPS responders (lpshigh) and low LPS responders (lpslow), based on the concentration of cytokines produced in response to LPS. Gene expression analysis was done using the Affymetrix U95AV2 human oligonucleotide arrays. Impact factor analysis was carried out using this dataset on all ten immune signaling pathways. Impact factor scores for IL-1 and IL-6 NetPath pathways in the lpshigh group have high values whereas impact factor scores for lpslow do not show any significant perturbation of NetPath pathways. The scores are consistent with experimental results showing upregulation of IL-1 and IL-6 ligands in the lpshigh group. The impact factor gives the insight that not only are the ligands upregulated, but the pathway also seems to be highly affected. It should be noted that impact factor is not the only method to measure the biological impact of perturbation of pathways and other methods will continue to be developed and could be applied to such pathway data.
In addition to keeping these pathways updated on a regular basis, we will also add additional pathways to NetPath. We also hope to involve the biomedical community by allowing researchers to provide feedback as well as to volunteer to become 'pathway authorities' on specific pathways, similar to the successful contribution model of the BioCarta resource . In this regard, we have already recruited several investigators to serve as pathway authorities in our initial effort. Multiple pathway authorities are possible for the same pathway if there are enough interested investigators with expertise who wish to contribute in this fashion. For instance, ten other signaling pathways pertaining to cancer signaling were developed for the Cancer Cell Map project , as a collaboration with Memorial Sloan-Kettering Cancer Center, and these data are also available through Pathway Commons . We also intend to map our human-specific pathway data to corresponding mouse orthologs to create the mouse equivalent of our signaling pathways. Since large amounts of human signaling pathway data are modeled using the mouse, this will facilitate biological system modeling that relies on primary experimental data. We also intend to incorporate pathway visualization for all existing pathways in NetPath as well as those that will be added in the future using the PathVisio software . PathVisio also supports visualization of gene expression data in the context of pathways, which will enable biologists to display a systems view of the signaling pathway.
We have developed a resource for integration of human cellular signaling events. These pathway-specific protein-protein interaction data can be used to generate larger physical networks of protein-protein interactions that, when coupled with data on genetic interactions, could help in defining novel functional relationships among proteins. In addition, genetic interactions can functionally link proteins that belong to unconnected physical networks. These pathways could also be used to interrogate gene expression signatures in cancers and other human diseases to better understand the mechanisms or to obtain profiles for diagnostic or therapeutic purposes. There is a large amount of known information about different cellular signaling pathways controlling a variety of cellular functions, which is difficult to collect by one group. We support the vision of many data providers collecting data of interest and making them freely available in standard formats as a scalable way to represent all known pathway information in databases for comprehensive analysis. Overall, we hope to engage the biomedical community in keeping the NetPath pathway resource up to date and as error-free as possible.
Materials and methods
The initial annotation process of any signaling pathway involves gathering and reading of review articles to achieve a brief overview of the pathway. This process is followed by listing all the molecules that arereported to be involved in the pathway under annotation. Information regarding potential pathway authorities are also gathered at this initial stage. Pathway experts are involved in initial screening of the molecules listed to check for any obvious omissions. In the second phase, annotators manually perform extensive literature searches using search keys, which include all the alternative names of the molecules involved, the name of the pathway, the names of reactions, and so on. In addition, the iHOP  resource is also used to perform advanced PubMed-based literature searches to collect the reactions that were reported to be implicated in a given pathway. The collected reactions are manually entered using the PathBuilder  annotation interface, which is subjected to an internal review process involving PhD level scientists with expertise in the areas of molecular biology, immunology and biochemistry. However, there are instances where a molecule has been implicated in a pathway in a published report but the associated experimental evidence is either weak or differs from experiments carried out by other groups. For this purpose, we recruit several investigators as pathway authorities based on their expertise in individual signaling pathways. The review by pathway authorities occasionally leads to correction of errors or, more commonly, to inclusion of additional information. Finally, the pathway authorities help in assessing whether the work of all major laboratories has been incorporated for the given signaling pathway.
Biological Pathways Exchange
Gene Expression Omnibus
high mobility group box protein 1
Human Protein Reference Database
Kyoto Encyclopedia of Genes and Genomes
Proteomics Standards Initiative - Molecular Interactions
Systems Biology Markup Language.
Akhilesh Pandey is supported by grants from Johns Hopkins Breast Cancer SPORE (CA 88843) Career Development Award, Department of Defense Era of Hope Scholar (W81XWH-06-1-0428) and partly by National Institutes of Health grant U54 RR020839 (Roadmap Initiative for Technology Centers for Networks and Pathways).
- Fukuda K, Takagi T: Knowledge representation of signal transduction pathways. Bioinformatics. 2001, 17: 829-837. 10.1093/bioinformatics/17.9.829.PubMedView ArticleGoogle Scholar
- Uetz P, Finley RL: From protein networks to biological systems. FEBS Lett. 2005, 579: 1821-1827. 10.1016/j.febslet.2005.02.001.PubMedView ArticleGoogle Scholar
- Ideker T: A systems approach to discovering signaling and regulatory pathways - or, how to digest large interaction networks into relevant pieces. Adv Exp Med Biol. 2004, 547: 21-30.PubMedView ArticleGoogle Scholar
- Schaefer CF: Pathway databases. Ann N Y Acad Sci. 2004, 1020: 77-91. 10.1196/annals.1310.009.PubMedView ArticleGoogle Scholar
- NetPath. [http://www.netpath.org/]
- Kandasamy K, Keerthikumar S, Raju R, Keshava Prasad TS, Ramachandra YL, Mohan S, Pandey A: PathBuilder - open source software for annotating and developing pathway resources. Bioinformatics. 2009, 25: 2860-2862. 10.1093/bioinformatics/btp453.PubMedPubMed CentralView ArticleGoogle Scholar
- BioPAX: Biological Pathways Exchange. [http://www.biopax.org/]
- Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, Ceol A, Moore S, Orchard S, Sarkans U, von Mering C, Roechert B, Poux S, Jung E, Mersch H, Kersey P, Lappe M, Li Y, Zeng R, Rana D, Nikolski M, Husi H, Brun C, Shanker K, Grant SG, Sander C, Bork P, Zhu W, Pandey A, Brazma A, Jacq B, et al: The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat Biotechnol. 2004, 22: 177-183. 10.1038/nbt926.PubMedView ArticleGoogle Scholar
- Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, Cuellar AA, Dronov S, Gilles ED, Ginkel M, Gor V, Goryanin II, Hedley WJ, Hodgman TC, Hofmeyr JH, Hunter PJ, Juty NS, Kasberger JL, Kremling A, Kummer U, Le Novere N, Loew LM, Lucio D, Mendes P, Minch E, Mjolsness ED, et al: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics. 2003, 19: 524-531. 10.1093/bioinformatics/btg015.PubMedView ArticleGoogle Scholar
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13: 2498-2504. 10.1101/gr.1239303.PubMedPubMed CentralView ArticleGoogle Scholar
- The Cancer Cell Map. [http://cancer.cellmap.org/]
- Bader GD, Cary MP, Sander C: Pathguide: a pathway resource list. Nucleic Acids Res. 2006, 34: D504-506. 10.1093/nar/gkj126.PubMedPubMed CentralView ArticleGoogle Scholar
- Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27.PubMedPubMed CentralView ArticleGoogle Scholar
- BioCarta. [http://www.biocarta.com/]
- Connections Maps. [http://stke.sciencemag.org/cm]
- Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B, Jassal B, Gopinath GR, Wu GR, Matthews L, Lewis S, Birney E, Stein L: Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 2005, 33: D428-432. 10.1093/nar/gki072.PubMedPubMed CentralView ArticleGoogle Scholar
- NCI-Nature Pathway Interaction Database. [http://pid.nci.nih.gov/]
- Cell Signaling Technology. [http://www.cellsignal.com/]
- INOH Pathway Database. [http://www.inoh.org/]
- Signaling Pathway Database. [http://www.grt.kyushu-u.ac.jp/spad]
- Hackl H, Maurer M, Mlecnik B, Hartler J, Stocker G, Miranda-Saavedra D, Trajanoski Z: GOLD.db: genomics of lipid-associated disorders database. BMC Genomics. 2004, 5: 93-10.1186/1471-2164-5-93.PubMedPubMed CentralView ArticleGoogle Scholar
- Demir E, Babur O, Dogrusoz U, Gursoy A, Nisanci G, Cetin-Atalay R, Ozturk M: PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways. Bioinformatics. 2002, 18: 996-1003. 10.1093/bioinformatics/18.7.996.PubMedView ArticleGoogle Scholar
- Ng A, Bursteinas B, Gao Q, Mollison E, Zvelebil M: pSTIING: a 'systems' approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer. Nucleic Acids Res. 2006, 34: D527-534. 10.1093/nar/gkj044.PubMedPubMed CentralView ArticleGoogle Scholar
- Zheng CJ, Zhou H, Xie B, Han LY, Yap CW, Chen YZ: TRMP: a database of therapeutically relevant multiple pathways. Bioinformatics. 2004, 20: 2236-2241. 10.1093/bioinformatics/bth233.PubMedView ArticleGoogle Scholar
- Pico AR, Kelder T, van Iersel MP, Hanspers K, Conklin BR, Evelo C: WikiPathways: pathway editing for the people. PLoS Biol. 2008, 6: e184-10.1371/journal.pbio.0060184.PubMedPubMed CentralView ArticleGoogle Scholar
- Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A, Narechania A: PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13: 2129-2141. 10.1101/gr.772403.PubMedPubMed CentralView ArticleGoogle Scholar
- Nakamura M, Asao H, Takeshita T, Sugamura K: Interleukin-2 receptor heterotrimer complex and intracellular signaling. Semin Immunol. 1993, 5: 309-317. 10.1006/smim.1993.1037.PubMedView ArticleGoogle Scholar
- Morgan DA, Ruscetti FW, Gallo R: Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976, 193: 1007-1008. 10.1126/science.181845.PubMedView ArticleGoogle Scholar
- Mingari MC, Gerosa F, Carra G, Accolla RS, Moretta A, Zubler RH, Waldmann TA, Moretta L: Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature. 1984, 312: 641-643. 10.1038/312641a0.PubMedView ArticleGoogle Scholar
- London L, Perussia B, Trinchieri G: Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J Immunol. 1986, 137: 3845-3854.PubMedGoogle Scholar
- Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med. 1982, 155: 1823-1841. 10.1084/jem.155.6.1823.PubMedView ArticleGoogle Scholar
- Greene WC, Leonard WJ: The human interleukin-2 receptor. Annu Rev Immunol. 1986, 4: 69-95. 10.1146/annurev.iy.04.040186.000441.PubMedView ArticleGoogle Scholar
- Green DR, Droin N, Pinkoski M: Activation-induced cell death in T cells. Immunol Rev. 2003, 193: 70-81. 10.1034/j.1600-065X.2003.00051.x.PubMedView ArticleGoogle Scholar
- Malek TR, Bayer AL: Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004, 4: 665-674. 10.1038/nri1435.PubMedView ArticleGoogle Scholar
- Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature. 2001, 411: 380-384. 10.1038/35077246.PubMedView ArticleGoogle Scholar
- Paredes R, Lopez Benaldo de Quiros JC, Fernandez-Cruz E, Clotet B, Lane HC: The potential role of interleukin-2 in patients with HIV infection. AIDS Rev. 2002, 4: 36-40.PubMedGoogle Scholar
- Kim HP, Imbert J, Leonard WJ: Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006, 17: 349-366. 10.1016/j.cytogfr.2006.07.003.PubMedView ArticleGoogle Scholar
- Leonard WJ: Type I Cytokines and Interferons and Their Receptors. Fundamental Immunology. 2008, Philadelphia: Lippincott Williams & Wilkins, 701-749. 6Google Scholar
- Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993, 73: 147-157. 10.1016/0092-8674(93)90167-O.PubMedView ArticleGoogle Scholar
- Lin JX, Leonard WJ: Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 1997, 8: 313-332. 10.1016/S1359-6101(97)00021-X.PubMedView ArticleGoogle Scholar
- Ellery JM, Nicholls PJ: Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev. 2002, 13: 27-40. 10.1016/S1359-6101(01)00023-5.PubMedView ArticleGoogle Scholar
- Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN: Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA. 1997, 94: 3627-3632. 10.1073/pnas.94.8.3627.PubMedPubMed CentralView ArticleGoogle Scholar
- HPRD: Human Protein Reference Database. [http://www.hprd.org/]
- Prasad TSK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Kishore CJH, Kanth S, Ahmed M, Kashyap M, Mohmood R, Ramachandra YL, Krishna V, Rahiman AB, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A: Human Protein Reference Database -- 2009 update. Nucleic Acids Res. 2009, 37: D767-D772. 10.1093/nar/gkn892.View ArticleGoogle Scholar
- Kandasamy K, Keerthikumar S, Mathivanan S, Patankar N, Shafreen B, Renuse S, Pawar H, Ramachandra YL, Prasad TSK, Acharya PK, Ranganathan P, Chaerkady R, Pandey A: Human Proteinpedia: A unified discovery resource for proteomics research. Nucleic Acids Res. 2009, 37: D773-D781. 10.1093/nar/gkn701.PubMedPubMed CentralView ArticleGoogle Scholar
- Cary MP, Bader GD, Sander C: Pathway information for systems biology. FEBS Lett. 2005, 579: 1815-1820. 10.1016/j.febslet.2005.02.005.PubMedView ArticleGoogle Scholar
- Creative Commons license version 2.5. [http://creativecommons.org/licenses/by/2.5/]
- Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R: A systems biology approach for pathway level analysis. Genome Res. 2007, 17: 1537-1545. 10.1101/gr.6202607.PubMedPubMed CentralView ArticleGoogle Scholar
- Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R: NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res. 2007, 35: D760-765. 10.1093/nar/gkl887.PubMedPubMed CentralView ArticleGoogle Scholar
- Silva E, Arcaroli J, He Q, Svetkauskaite D, Coldren C, Nick JA, Poch K, Park JS, Banerjee A, Abraham E: HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Medicine. 2007, 33: 1829-1839. 10.1007/s00134-007-0748-2.PubMedView ArticleGoogle Scholar
- Wurfel MM, Park WY, Radella F, Ruzinski J, Sandstrom A, Strout J, Bumgarner RE, Martin TR: Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol. 2005, 175: 2570-2578.PubMedView ArticleGoogle Scholar
- Pathway Commons. [http://www.pathwaycommons.org/]
- van Iersel MP, Kelder T, Pico AR, Hanspers K, Coort S, Conklin BR, Evelo C: Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics. 2008, 9: 399-10.1186/1471-2105-9-399.PubMedPubMed CentralView ArticleGoogle Scholar
- Hoffmann R, Valencia A: A gene network for navigating the literature. Nat Genet. 2004, 36: 664-10.1038/ng0704-664.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.